aica ribonucleotide and Familial Nonmedullary Thyroid Cancer

aica ribonucleotide has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrade, BM; Carvalho, DP; Cazarin, JM; Coelho, RG; Hecht, F1

Other Studies

1 other study(ies) available for aica ribonucleotide and Familial Nonmedullary Thyroid Cancer

ArticleYear
5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Thyroid : official journal of the American Thyroid Association, 2016, Volume: 26, Issue:7

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Humans; Neoplasm Invasiveness; Ribonucleotides; Thyroid Cancer, Papillary; Thyroid Neoplasms

2016